EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Query: ((BF = "32014R0536" AND DD = 31/01/2022) OR (RESOURCE_LEGAL_CORRECTS_RESOURCE_LEGAL = "32014R0536" AND DD >= 31/01/2022 AND DD < 06/07/2022 AND (EMBEDDED_ACT_CONSOLIDATED_DATE > 31/01/2022 OR EMBEDDED_ACT_CONSOLIDATED_DATE = NULL)) OR ((RESOURCE_LEGAL_REPEALS_RESOURCE_LEGAL = "32014R0536" OR RESOURCE_LEGAL_IMPLICITLY_REPEALS_RESOURCE_LEGAL = "32014R0536" OR RESOURCE_LEGAL_RENDERS_OBSOLETE_RESOURCE_LEGAL = "32014R0536" OR RESOURCE_LEGAL_REPLACES_RESOURCE_LEGAL = "32014R0536" OR RESOURCE_LEGAL_SUSPENDS_RESOURCE_LEGAL = "32014R0536" OR RESOURCE_LEGAL_PARTIALLY_SUSPENDS_RESOURCE_LEGAL = "32014R0536" OR RESOURCE_LEGAL_AMENDS_RESOURCE_LEGAL = "32014R0536") AND DD > 31/01/2022 AND DD <= 06/07/2022)) AND (EMBEDDED_WHE_EXPRESSION_LG=ENG), Search language: English

Regulation (EU) 2022/641 of the European Parliament and of the Council of 12 April 2022 amending Regulation (EU) No 536/2014 as regards a derogation from certain obligations concerning investigational medicinal products made available in the United Kingdom in respect of Northern Ireland and in Cyprus, Ireland and Malta (Text with EEA relevance)

PE/7/2022/REV/1

In force

CELEX number:
32022R0641
Form:
Regulation
Author:
European Parliament, Council of the European Union
Date of document:
12/04/2022; Date of signature